Benralizumab Proves Effective for Eosinophilic Granulomatosis With Polyangiitis
(MedPage Today) -- At the recent American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting, researchers reported that treatment with benralizumab (Fasenra) was noninferior to mepolizumab (Nucala) for relapsing or refractory eosinophilic... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 20, 2024 Category: Allergy & Immunology Source Type: news

First Treatment Approved for Chronic Rhinosinusitis Without Nasal Polyps
(MedPage Today) -- The FDA expanded the approval of fluticasone propionate (Xhance) nasal spray for chronic rhinosinusitis to also include treatment of adults without nasal polyps, manufacturer Optinose announced on Friday. The drug-device combination... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 19, 2024 Category: Allergy & Immunology Source Type: news

Another Dangerous Amoeba Linked to Neti Pots and Nasal Rinsing
(MedPage Today) -- For years, scientists have known people who use neti pots can become infected with a brain-eating amoeba if they use the wrong kind of water. On Wednesday, researchers linked a second kind of deadly amoeba to nasal rinsing.... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 14, 2024 Category: Allergy & Immunology Source Type: news

Three Trials Examine Dupilumab in Moderate-to-Severe Asthma
(MedPage Today) -- Three abstracts evaluating dupilumab (Dupixent) for moderate-to-severe asthma were presented at the recent American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting: VESTIGE, a phase IV trial which evaluated... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 12, 2024 Category: Allergy & Immunology Source Type: news

AAAAI Roundup: Perioperative Assessment of Antibiotic Allergy With a Mobile App
(MedPage Today) -- WASHINGTON -- Posters at the American Academy of Allergy, Asthma & Immunology annual meeting provided data about an antibiotic allergy assessment tool via a smartphone app, a direct oral challenge (DOC) for assessing low... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 4, 2024 Category: Allergy & Immunology Source Type: news

Medicaid Expansion and Healthcare Workers; Cardiac Rehabilitation
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 2, 2024 Category: Allergy & Immunology Source Type: news

Epinephrine Nasal Spray Starts Reversing Allergic Reactions in Minutes
(MedPage Today) -- WASHINGTON -- Although FDA approval has eluded the intranasal epinephrine spray ARS-1 (also known as neffy), it continued to build its case with findings of resolved allergic symptoms in children and teenagers undergoing an... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 2, 2024 Category: Allergy & Immunology Source Type: news

Peanut Allergen Sensitization Seen in Younger Siblings of LEAP Study Participants
(MedPage Today) -- WASHINGTON -- Among the younger siblings of children who consumed peanut allergens as part of the LEAP trial, there was a trend toward peanut sensitization, though this effect was reduced if peanut was introduced early, results... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 1, 2024 Category: Allergy & Immunology Source Type: news

Indoor Pest Exposures Tied to Respiratory Issues in Kids With Asthma
(MedPage Today) -- WASHINGTON -- Among kids with asthma, indoor allergen exposure to pests like mice and cockroaches was associated with occurrence of upper respiratory infections (URIs), according to a longitudinal study. Among 90 mostly Black... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 1, 2024 Category: Allergy & Immunology Source Type: news

Novel Antibody for Chronic Hives Brings Relief in Mid-Stage Trial
(MedPage Today) -- WASHINGTON -- Barzolvolimab, a first-in-class anti-KIT monoclonal antibody, reduced the severity of hives in adults with chronic spontaneous urticaria (CSU) who remained symptomatic on antihistamines, a randomized phase II... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - February 29, 2024 Category: Allergy & Immunology Source Type: news

Oral Drug Gains Steam as On-Demand Option for Hereditary Angioedema Attacks
(MedPage Today) -- WASHINGTON -- The investigational oral drug sebetralstat provided on-demand relief during tissue swelling attacks from hereditary angioedema (HAE), a phase III study showed. Following self-administration, time to the beginning... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - February 28, 2024 Category: Allergy & Immunology Source Type: news

Dupilumab Cuts Lung Inflammation, Breaks Up Mucus Plugs in Asthma Patients
(MedPage Today) -- WASHINGTON -- Dupilumab (Dupixent) reduced airway inflammation and increased lung capacity in patients with uncontrolled, moderate-to-severe asthma, while also reducing troublesome mucus plugs, a multinational postmarketing... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - February 26, 2024 Category: Allergy & Immunology Source Type: news

Asthma Control Better With Biologic-Corticosteroid Combo
(MedPage Today) -- WASHINGTON -- Adding dupilumab (Dupixent) to a medium-dose inhaled corticosteroid (ICS) routine helped lower asthma exacerbations and improved both lung function and asthma control, according to a post-hoc analysis of the LIBERTY... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - February 26, 2024 Category: Allergy & Immunology Source Type: news

Drug Slashes Risk of Severe Allergic Reactions to Multiple Foods
(MedPage Today) -- WASHINGTON -- Regular courses of omalizumab (Xolair) injections increased the amount of peanut and other foods that multi-food allergic children could consume without an allergic reaction, data from the first stage of the randomized... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - February 26, 2024 Category: Allergy & Immunology Source Type: news

Benralizumab Matches Mepolizumab for Rare Vasculitis
(MedPage Today) -- WASHINGTON -- Treatment with benralizumab (Fasenra) was noninferior to mepolizumab (Nucala) for relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA), the randomized MANDARA trial showed. Among 140 patients... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - February 24, 2024 Category: Allergy & Immunology Source Type: news